BRIEF-Moleculin Announces New Pre-Clinical Data For Annamycin

Reuters
29 Apr
BRIEF-Moleculin Announces New Pre-Clinical Data For Annamycin

April 29 (Reuters) - Moleculin Biotech Inc MBRX.O:

  • MOLECULIN ANNOUNCES NEW PRE-CLINICAL DATA FOR ANNAMYCIN DEMONSTRATING MARKET EXPANSION POTENTIAL INCLUDING TREATMENT FOR PANCREATIC CANCER

Source text: ID:nGNX6GVSWC

Further company coverage: MBRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10